
    
      Eligible breast cancer patients with mastectomy and axillary dissection are randomized into 2
      groups:radiotherapy of 50 Gy in 25 fractions within 5 weeks to ipsilateral chest wall and
      supraclavicular nodal region,and no radiotherapy.

      During and after radiotherapy, the patients are followed and the efficacy and toxicities of
      radiotherapy are evaluated.
    
  